Intervention Review

You have free access to this content

Post-exposure passive immunisation for preventing measles

  1. Megan K Young1,*,
  2. Graeme R Nimmo2,
  3. Allan W Cripps3,
  4. Mark A Jones4

Editorial Group: Cochrane Acute Respiratory Infections Group

Published Online: 1 APR 2014

Assessed as up-to-date: 14 AUG 2013

DOI: 10.1002/14651858.CD010056.pub2


How to Cite

Young MK, Nimmo GR, Cripps AW, Jones MA. Post-exposure passive immunisation for preventing measles. Cochrane Database of Systematic Reviews 2014, Issue 4. Art. No.: CD010056. DOI: 10.1002/14651858.CD010056.pub2.

Author Information

  1. 1

    Griffith University, School of Medicine, Griffith Health Institute, Meadowbrook, Queensland, Australia

  2. 2

    Pathology Queensland, Department of Microbiology, Brisbane, Queensland, Australia

  3. 3

    Griffith University, Griffith Health, Gold Coast, Queensland, Australia

  4. 4

    The University of Queensland, School of Population Health, Brisbane, Queensland, Australia

*Megan K Young, School of Medicine, Griffith Health Institute, Griffith University, University Drive, Meadowbrook, Queensland, 4121, Australia. megan.young@griffith.edu.au.

Publication History

  1. Publication Status: New
  2. Published Online: 1 APR 2014

SEARCH

[Figure 1]
Figure 1. Flow diagram of retrieval, selection and exclusion of studies.
[Figure 2]
Figure 2. 'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study.
[Analysis 1.1]
Analysis 1.1. Comparison 1 Immunoglobulin versus no treatment, Outcome 1 Measles cases.
[Analysis 1.2]
Analysis 1.2. Comparison 1 Immunoglobulin versus no treatment, Outcome 2 Measles cases.
[Analysis 1.3]
Analysis 1.3. Comparison 1 Immunoglobulin versus no treatment, Outcome 3 Measles cases.
[Analysis 1.4]
Analysis 1.4. Comparison 1 Immunoglobulin versus no treatment, Outcome 4 Mortality due to measles.
[Analysis 1.5]
Analysis 1.5. Comparison 1 Immunoglobulin versus no treatment, Outcome 5 Complications due to measles.
[Analysis 2.1]
Analysis 2.1. Comparison 2 Gamma globulin versus serum, Outcome 1 Measles cases.